COMMUNIQUÉS West-GlobeNewswire

Response to attacks against Carbios and its executives
04/03/2026
Clermont-Ferrand (France), March 4, 2026 (8:45 a.m. CET). Carbios (Euronext Growth Paris : ALCRB) denounces the destabilization operation to which it has been subjected for several months and formally contests all [...]
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
04/03/2026
REYKJAVIK, ICELAND (March 4, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today [...]
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
04/03/2026
REYKJAVIK, Iceland, March 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
04/03/2026
— Second clinical candidate from HUTCHMED’s next-generation ATTC platform — — Leveraging synergy through simultaneous inhibition of PAM pathway and EGFR signaling — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March [...]
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
04/03/2026
Daridorexant is a dual orexin receptor antagonist being developed in South Korea by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ® Phase 3 trial of daridorexant [...]
AudiLeaf Ear Health Claims Evaluated: 2026 Report Examines Ingredients, Proprietary Blend Dosing, and What Consumers Should Verify Before Buying
04/03/2026
A 2026 informational consumer evaluation of AudiLeaf's ear health marketing claims, proprietary herbal blend ingredient research context, pricing structure, and what to verify before purchasing Aurora, CO, March 03, [...]
Male Power XL "Black Elixir" Claims Evaluated: 2026 Report Examines Ingredient Research, Proprietary Blend Transparency, and What Men Should Verify Before Buying
04/03/2026
A 2026 informational consumer report evaluating Male Power XL's "black elixir" marketing language, ingredient research context, proprietary blend limitations, pricing and policy terms shown on the official site, and [...]
MemoTril Cognitive Support Claims Evaluated: Latest 2026 Consumer Report Examines MemoTril Brain Supplement Ingredients, Memory Enhancement Marketing, and What Consumers Should Verify
04/03/2026
Informational 2026 consumer report examining MemoTril brain supplement ingredients, cognitive support marketing claims, ingredient research context, pricing disclosures, and what consumers should verify before [...]
DermaFix Nail Fungus Treatment Gel Claims Evaluated in 2026 Market Report Covering Tea Tree Oil Research, Penetration Technology Positioning, and Pricing Transparency
04/03/2026
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and publicly listed pricing structures in the topical nail fungus category Sheridan, WY, March 03 [...]
Vaxart to Host Upcoming Conference Calls
03/03/2026
Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ET Stockholder fireside chat to be held on March 13 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 03, 2026 ( [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/03/2026
NEW YORK and WALTHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
03/03/2026
THE WOODLANDS, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in an upcoming fireside chat at the 2026 Leerink Partners [...]
Teladoc Health to Participate in Upcoming Investor Conference
03/03/2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the Barclays 28th Annual [...]
LifeMD to Participate in Two Investor Conferences During March
03/03/2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences [...]
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
03/03/2026
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
03/03/2026
Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression are safe and well-tolerated, evade detection by the [...]
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
03/03/2026
ZUG, Switzerland, March 03, 2026 (GLOBE NEWSWIRE) -- Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from [...]
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
03/03/2026
Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from DIAMOND Phase 3 trials with OCS-01 eye drops in diabetic [...]
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026
03/03/2026
CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare [...]

Pages